Reckitt Benckiser Group plc (RBGPF) Stock

About Reckitt Benckiser Group plc

Reckitt Benckiser Group Plc engages in the manufacture and trade of consumer brand products including Air Wick, Calgon, Cillit Bang, Clearasil, Dettol, Durex, Enfamil, Finish, Gaviscon, Harpic, Lysol, Mortein, Mucinex, Nurofen, Nutramigen, Strepsils, Vanish, Veet, and Woolite. It operates through the following segments: Hygiene, Health, and Nutrition. The company was founded by Isaac Reckitt in 1840 and is headquartered in Slough, the United Kingdom.

Reckitt Benckiser Group plc is headquartered in GB.

Reckitt Benckiser Group plc (RBGPF) stock trades at $69.00 with a market capitalization of $43.82B. The stock is valued at a price-to-earnings (P/E) ratio of 11.19, price-to-book of 5.69, price-to-sales of 2.32. Over the past 52 weeks the stock has ranged between $58.67 and $90.71, and currently trades 23.9% below its 52-week high. It pays a dividend yielding 3.46%.

On profitability, Reckitt Benckiser Group plc generates a return on equity (ROE) of 42.87%, above the typical market range of roughly 12-15%, return on capital employed of 23.92%, an operating margin of 28.49%, a net profit margin of 21.09%.

In its most recent fiscal year, Reckitt Benckiser Group plc reported annual revenue of $14.2B, net profit of $3.2B. Over the last 5 fiscal years, revenue grew at an average annual rate of 0.3%, and net profit grew at an average annual rate of 21.8%. Over that span net profit grew faster than revenue, so net margin widened.

The balance sheet shows a debt-to-equity ratio of 1.79, a current ratio of 0.59, total assets of $25.1B, $2.0B in cash and equivalents.

RBGPF has an average daily trading volume of 1,707 shares, a beta of 0.26 (historically less volatile than the overall market).

Official website: www.reckitt.com